Israel's Vaxival Bios develops cancer vaccine "ImMucin" to stop cancer recurrence
-
Last Update: 2020-06-09
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
Recent lying news emerged that http:// an Israeli biotechcompany, had developed a revolutionary cancer vaccine, ImMucin,Vaxil Bios, specifically designed to prevent a recurrence after cancer treatmentThe vaccine can instruct the body's immune cells to identify the mutated cancer cells and destroy them before they form cancer againAbout the cancer vaccine "ImMucin"ImMucin is as broad-spectrum as any other vaccine, is suitable for most people, and is suitable for 90% of cancer types without affecting the surroundinghealthy(http://cells and tissues"ImMucin" is a scientifically effective vaccine, but unlike those with cancer prevention, it is a cancer immunotherapeutic vaccineAbout Vaxill Bios
Vaxil, a cancer research biotechnology company focused on innovative immunotherapy, has been awarded thepatent(http://by many countries around the world ImMucin has also been designated by the U.S Drug Administration and the European Drug (http:// Administration as orphans for multiple myeloma Vaxil is currently clinically experimentally working on ImMucin's applicability to other MUC1 cancer types and hopes to bring the product (http:// to market as soon as possible through Phase III clinical trials
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
